REMplenish After Shark Tank: A $400,000 Deal and the Evidence Behind the Nozzle
Anders Olmanson traded 10% on air for $400,000. The nozzle’s design, sales history and clinical research each answer a different question.
It is easy to promise to do a set of exercises every day. Remembering to do them for weeks is a different problem. Former Medtronic engineer Anders Olmanson approached that problem through a habit most people already have: drinking water. His REMplenish nozzle adds resistance while the user drinks, so the exercise takes place during the day rather than requiring a device to be worn in bed.
The proposition drew two investors and $400,000 on Shark Tank. It also raises a question the investment itself cannot answer: does a person using this particular nozzle get a meaningful improvement in sleep or breathing? The commercial and clinical evidence deserve separate treatment.
On-air deal
Pitch outcome
$400,000 for 10% with Kevin O’Leary and Daniel Lubetzky.
$400,000 for 4%
Opening ask
Terms sought on Shark Tank.
$3.9 million
Product detail
Reported 2024 sales, not a clinical result.
Product snapshot
| Field | Details |
|---|---|
| Company | REMplenish |
| Founder or founding team | Anders Olmanson |
| Product | Resistance nozzle and straw for a water bottle |
| Industry | Sleep and airway wellness |
| Shark Tank episode | Season 17, Episode 14 • March 18, 2026 |
| Current status | The official store lists nozzles, bottles and kits. |
How does REMplenish work?
REMplenish pairs a straw with a shaped nozzle intended to train muscles in the tongue and upper airway as someone drinks. The official shop offers bottles and nozzle configurations. The idea borrows from myofunctional therapy, which involves exercises for the mouth and related muscles. It does not measure breathing overnight or diagnose a sleep disorder.
A Mayo Clinic study registered at ClinicalTrials.gov investigated the device. A feasibility study can show whether people are able and willing to use a product as directed. That is different from demonstrating that it replaces an established treatment or produces a specific clinical benefit for everyone who buys it.
Who built REMplenish?
Olmanson brought engineering experience to a behavioral problem. The product had to deliver resistance while still being something a person would use as part of an ordinary drinking routine. The company’s news archive documents research interest in the technology before the Shark Tank episode. That chronology matters: television introduced the product to new viewers; it did not initiate the research.
The water-bottle nozzle featured in the company’s catalog.
“As seen March 18 on ABC’s Shark Tank!” — REMplenish’s product catalog.
What happened to REMplenish on Shark Tank?
Olmanson asked for 4%, implying a $10 million post-money price. The sales discussed rose from about $1.1 million in 2023 to $3.9 million in 2024. Forecasts of $8 million to $10 million were projections, not results. Reported reactions touched on two distinct concerns: Robert Herjavec found the mouthpiece uncomfortable, and Lori Greiner wanted more evidence of efficacy.
O’Leary and Lubetzky ultimately agreed on $400,000 for 10%. Olmanson tried 8% before accepting. The final terms implied a $4 million post-money price at the time of the agreement, well below the opening ask. Episode reporting.
Deal snapshot
| Negotiation point | What the evidence supports |
|---|---|
| Asked | $400,000 for 4% |
| On-air outcome | $400,000 for 10% with Kevin O’Leary and Daniel Lubetzky. |
| Key negotiating point | A proposed 8% counter did not displace the Sharks’ 10% terms. |
Why a daily habit matters to both the customer and the company
A wellness company can make a sale by explaining the idea once. Its longer-term reputation depends on whether customers use the device correctly and continue long enough to make a fair assessment. For a nozzle, comfort, resistance, cleaning and the availability of instruction all influence actual use. These details are part of the product, not just customer support.
A study that measures adherence can therefore be commercially relevant even when it does not settle medical efficacy. It tells a product designer about the gap between someone agreeing to try the nozzle and actually using it. An investor still needs separate information about advertising, returns, manufacturing and repeat or replacement sales.
Business model snapshot
| Business question | Answer |
|---|---|
| Product | Resistance nozzle and straw for a water bottle |
| Sales channel | Direct sales of nozzle kits, accessories and bottles. |
| Buyer decision | Check the exact nozzle level and what is included in the kit. |
| Business question | Does the product remain comfortable and useful enough for customers to keep using it? |
What happened after Shark Tank?
Latest update — November 12, 2026. REMplenish maintains a product catalog, instructions and research resources. The registered study is identifiable independently of the brand’s marketing.
The company’s research summary describes a feasibility study reaching an adherence goal. That wording is specific. It should not be expanded into a claim that the nozzle cures sleep apnea or replaces prescribed therapy. People with diagnosed or suspected sleep apnea should discuss treatment decisions with a qualified clinician.
Current status evidence
| Evidence | What it establishes |
|---|---|
| Official offering | The official store lists nozzles, bottles and kits. |
| Pitch evidence | $400,000 for 10% with Kevin O’Leary and Daniel Lubetzky. |
| What is still unknown | Current private earnings, final deal documents and individual treatment outcomes. |
Company timeline
| Date | Milestone |
|---|---|
| 2023 | The company reported $1.1 million in sales; research interest was already documented. |
| 2024 | Reported sales reached about $3.9 million. |
| March 18, 2026 | Olmanson accepted the joint offer on air. |
| November 2026 | Kits and research information remain available. |
What should a buyer check?
Compare the current kit contents, instructions and return terms. For a sleep-related concern, distinguish what your clinician wants to measure from what the device is designed to train. Someone who snores or has witnessed pauses in breathing needs an appropriate assessment; an improvement in how strong a tongue exercise feels cannot diagnose or rule out sleep apnea.
What can founders learn from REMplenish?
A product can have promising sales, a sensible mechanism and a study under way while important questions remain open. A founder who can explain precisely which result each piece of evidence supports earns more credibility than one who treats every positive signal as proof of the same claim.
The Season 17 episode guide lists the other pitches. Readers following the other investment decisions in this part of Season 17 can also find Rip Tie Hair, Clean Green Golf Balls, Nude Foods Market.
Frequently asked questions
Who presented REMplenish on Shark Tank? Anders Olmanson
What did the founders ask for? $400,000 for 4%.
What happened in the negotiation? $400,000 for 10% with Kevin O’Leary and Daniel Lubetzky.
Is REMplenish still operating? The official store lists nozzles, bottles and kits.
Is the nozzle a substitute for prescribed sleep-apnea treatment? The cited feasibility research does not establish that. Discuss any change in treatment with your clinician.
The weekly question
From obsession to clarity — one original question every week.
We answer one noisy topic at a time, in full. No daily roundup, no thread bait — just the question, the principles, and the system.
